Gitman Paul

Director at BIOSPECIFICS TECHNOLOGIES CORP

Sold, on record
$9M
Dollars the filings state
Form 4 sales
18
Latest May 15, 2019
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusual
    May 27, 2015 2015

    Sold 24,000 shares at $42.00 ($1M)

    Gitman Paul, Director

    Sold 26.4% of holdings ($3.8M position)66,825 shares left3.3x usual sizeFiling

  2. 2 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    May 29, 2015 +2 days

    Sold 15,000 shares at $46.76 ($701k)

    Gitman Paul, Director

    Sold 22.4% of holdings ($3.1M position)51,825 shares left2x usual sizeFiling

  3. 3 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusual
    Jun 23, 2015 +25 days

    Sold 36,308 shares at $51.78 ($1.9M)

    Gitman Paul, Director

    Sold 41.2% of holdings ($4.6M position)51,825 shares left4.1x usual sizeFiling

  4. 4 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Jul 20, 2015 +27 days

    Sold 8,692 shares at $53.00 ($461k)

    Gitman Paul, Director

    Sold 14.4% of holdings ($3.2M position)51,825 shares left0.9x usual sizeFiling

  5. 5 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Aug 24, 2018 +1131 days

    Sold 11,825 shares at $51.17 ($605k)

    Gitman Paul, Director

    Sold 22.8% of holdings ($2.7M position)40,000 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusual
    Aug 29, 2018 +5 days

    Sold 20,000 shares at $49.72 ($994k)

    Gitman Paul, Director

    Sold 50% of holdings ($2M position)20,000 shares leftFiling

  7. 7 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Sep 7, 2018 +9 days

    Sold 1,000 shares at $57.64 ($58k)

    Gitman Paul, Director

    Sold 4.8% of holdings ($1.2M position)20,000 shares leftFiling

  8. 8 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPUnusual
    May 15, 2019 +250 days

    Sold 5,000 shares at $65.83 ($329k)

    Gitman Paul, Director

    Sold 25% of holdings ($1.3M position)15,000 shares left0.4x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (18)

Form 144 notices and Form 4 sales by Gitman Paul
Source
May 15, 2019May 17, 2019BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale5,000$329k25.0%UnusualSEC
Sep 7, 2018Sep 7, 2018BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale1,000$58k4.8%Plan not statedSEC
Aug 29, 2018Aug 29, 2018BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale20,000$994k50.0%UnusualSEC
Aug 24, 2018Aug 27, 2018BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale11,825$605k22.8%Plan not statedSEC
Jul 20, 2015Jul 21, 2015BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale8,692$461k14.4%Plan not statedSEC
Jun 23, 2015Jun 25, 2015BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale36,308$1.9M41.2%UnusualSEC
May 29, 2015Jun 1, 2015BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale15,000$701k22.4%Plan not statedSEC
May 27, 2015May 28, 2015BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale24,000$1M26.4%UnusualSEC
Jan 23, 2015Jan 26, 2015BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale5,887$241k8.8%Plan not statedSEC
Jan 16, 2015Jan 20, 2015BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale4,113$169k6.2%Plan not statedSEC
Nov 24, 2014Nov 26, 2014BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale7,600$300k10.2%Plan not statedSEC
Jun 12, 2014Jun 16, 2014BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale10,000$280k14.4%Plan not statedSEC
Jan 23, 2014Jan 23, 2014BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale10,000$250k14.4%Plan not statedSEC
Dec 9, 2013Dec 11, 2013BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale15,000$345k20.2%Plan not statedSEC
Nov 18, 2013Nov 20, 2013BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale7,000$154k10.5%Plan not statedSEC
Nov 11, 2013Nov 12, 2013BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale5,000$100k7.0%Plan not statedSEC
Sep 15, 2009Sep 17, 2009BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale12,500$343k25.8%UnusualSEC
Sep 15, 2009Sep 15, 2009BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale27,500$741k36.2%UnusualSEC